Enliven Therapeutics
ELVN
46.53
+0.12
+0.26%
Enliven Therapeutics
US · ELVN
#2416 by market cap
Listed 1970
46.53
+0.12
+0.26%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Quant vs Street three independent views, side by side
StockVane factor grade
B+
Momentum strategy signal
Hold
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Analyst consensus 10 analysts
Buy
Avg price target 74.88 +60.9%
Price target rangecurrent 46.53
Low70.00
Avg74.88
High82.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-11-13 | H.C. Wainwright | -- | Buy | 73.00 |
| 2026-11-06 | JonesTrading | -- | Buy | 70.00 |
| 2026-11-06 | Guggenheim | -- | Buy | 78.00 |
| 2026-11-05 | Stifel | -- | Buy | 82.00 |
| 2026-11-05 | Barclays | -- | Buy | 78.00 |
| 2026-10-19 | H.C. Wainwright | -- | Buy | 73.00 |
| 2026-10-07 | TD Cowen | -- | Buy | -- |
| 2026-10-07 | Barclays | -- | Buy | 78.00 |
| 2026-10-06 | William Blair | -- | Buy | -- |
| 2026-10-05 | Morgan Stanley | -- | Buy | 70.00 |
| 2026-10-02 | Morgan Stanley | -- | Buy | 70.00 |
| 2026-10-01 | J.P. Morgan | -- | Buy | 75.00 |
| 2026-08-22 | William Blair | -- | Buy | -- |
| 2026-08-18 | William Blair | -- | Buy | -- |
| 2026-08-18 | Barclays | -- | Buy | 78.00 |
| 2026-08-17 | Mizuho Securities | -- | Buy | 73.00 |
| 2026-08-13 | Stifel | -- | Buy | 82.00 |
| 2026-08-08 | LifeSci Capital | -- | Buy | 70.00 |
| 2026-08-07 | LifeSci Capital | -- | Buy | 70.00 |
| 2026-08-06 | JonesTrading | -- | Buy | 70.00 |
| 2026-08-06 | Baird | -- | Buy | 75.00 |
| 2026-08-06 | Clear Street | -- | Buy | 68.00 |
| 2026-08-06 | Stifel | -- | Buy | 82.00 |
| 2026-08-05 | TD Cowen | -- | Buy | -- |
| 2026-08-05 | Goldman Sachs | -- | Buy | 80.00 |
Price target trend monthly average, last 3 years
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Enliven Therapeutics discussion 0 comments